Evidence map›Paper›PMID 28637202›Full record

ArticleSchizophrenia bulletin2017

Adherence to Antipsychotic Medication and Criminal Recidivism in a Canadian Provincial Offender Population.

Stefanie N Rezansoff, Akm Moniruzzaman, Seena Fazel, Lawrence McCandless, Julian M Somers

Open access · bronzeAbstract read
In one paragraph

Article in Schizophrenia bulletin, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 47 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Antipsychotic treatment adherence and motor vehicle crash among drivers with schizophrenia: a case-crossover study.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2025
    Article
  5. Article
  6. Observational
  7. Article
  8. Article
  9. Article
  10. [Association Between Medication Compliance and Various Risky Behaviors in Patients With Schizophrenia].Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2023
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 3 countries.

Stefanie N RezansoffSomers Research Group, Faculty of Health Sciences, Simon Fraser University, Burnaby, BC, Canada.
Akm MoniruzzamanSomers Research Group, Faculty of Health Sciences, Simon Fraser University, Burnaby, BC, Canada.
Seena FazelDepartment of Psychiatry, Warneford Hospital, University of Oxford, Oxford, UK.
Lawrence McCandlessFaculty of Health Sciences, Simon Fraser University, Burnaby, BC, Canada.
Julian M SomersSomers Research Group, Faculty of Health Sciences, Simon Fraser University, Burnaby, BC, Canada.
Simon Fraser University · CAWarneford Hospital · GB

Funding

CIHR MFE148262CIHR SCT - 151611Wellcome Trust 202836Wellcome Trust 202836/Z/16/Z
6 · The paper itself

Abstract

Preliminary evidence suggests that adherence to antipsychotic medication reduces criminal recidivism among patients diagnosed with schizophrenia. However, existing studies operationalize antipsychotic adherence as a binary variable (usually using a threshold of ≥80%), which does not reflect the prevalence of suboptimal adherence in real-world settings. The purpose of the current analysis was to investigate the association between successive ordinal levels of antipsychotic adherence and criminal recidivism in a well-defined sample of offenders diagnosed with schizophrenia (n = 11462). Adherence was measured using the medication possession ratio (MPR) and analyzed as a time-dependent covariate in multivariable regression models. Data were drawn from linked, comprehensive diagnostic, pharmacy and justice system records, and individuals were followed for an average of 10 years. Adjusted rate ratios (ARR) and confidence intervals (CI) are reported. Overall mean MPR was 0.41. Increasing levels of antipsychotic adherence were not associated with progressively lower rates of offending. However, when compared to the reference group (MPR ≥ 80%) all lower adherence levels were significantly associated (P < .001) with increased risk of violent (ARR = 1.58; 95% CI = 1.46-1.71) and nonviolent (ARR = 1.41; 95% CI = 1.33-1.50) offenses. Significance was replicated in separate sensitivity analyses. Previously published studies reporting reductions in crime may have been influenced by antipsychotic adherence ≥80%. Binary operationalization of adherence is an inaccurate predictor of recidivism. Future research addressing functional outcomes of antipsychotic adherence should conceptualize adherence as an incremental independent variable.

Indexed as

Drug MonitoringAdultAntipsychotic AgentsBritish ColumbiaCriminalsFemaleFollow-Up StudiesHumansMaleMiddle AgedRecidivismSchizophreniaYoung AdultAntipsychotic Agentsadherence thresholdantipsychotic adherencecriminal recidivismmedication possession ratiopublic safety

Identifiers

PMID28637202
PMCPMC5581906
OpenAlexW2634755931

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.